AU Stock MarketDetailed Quotes
4DXO 4DMedical Ltd
- 0.069
- 0.0000.00%
20min DelayMarket Closed Oct 31 13:41 AET
28.33MMarket Cap0.00P/E (Static)
0.000High0.000Low0Volume0.000Open0.069Pre Close0.00Turnover0.14052wk High0.00%Turnover Ratio410.53MShares0.03052wk Low--EPS TTM22.47MFloat Cap0.140Historical High0.00P/E (Static)325.69MShs Float0.030Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
4DMedical Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|
| Operating cash flow (direct method) | ||||
| Cash income from operating activities | 66.85%-552.52K | 55.44%-1.67M | -152.37%-3.74M | -1.48M |
| Revenue from customers | 30.94%2.89M | 413.53%2.21M | -38.33%429.52K | --696.47K |
| Income from government grants | -15.88%12.68M | 19.26%15.08M | 76.37%12.64M | --7.17M |
| Other cash income from operating activities | 14.92%-16.12M | -12.71%-18.95M | -79.87%-16.81M | ---9.35M |
| Cash paid | -51.28%-30.84M | 3.47%-20.38M | -63.10%-21.12M | -12.95M |
| Payments to suppliers for goods and services | -51.28%-30.84M | 3.47%-20.38M | -63.10%-21.12M | ---12.95M |
| Direct interest paid | 10.21%-263.96K | -63.71%-293.96K | -194.60%-179.56K | ---60.95K |
| Direct interest received | 103.65%1.24M | 556.10%607.57K | 197.18%92.6K | --31.16K |
| Direct tax refund paid | 50.61%-452.38K | -182.05%-915.86K | -435.28%-324.72K | ---60.66K |
| Operating cash flow | -36.26%-30.87M | 10.35%-22.65M | -74.03%-25.27M | ---14.52M |
| Investing cash flow | ||||
| Cash flow from continuing investing activities | -2,381.23%-40.04M | 53.90%-1.61M | -503.12%-3.5M | -580.45K |
| Net PPE purchase and sale | 62.95%-156.11K | 84.08%-421.33K | -359.29%-2.65M | ---576.35K |
| Net intangibles purchas and sale | 52.65%-146.76K | 28.08%-309.98K | -189.93%-430.99K | ---148.65K |
| Net business purchase and sale | ---38.87M | ---- | ---- | ---- |
| Net other investing changes | 1.25%-871.37K | -108.79%-882.42K | -392.37%-422.63K | --144.55K |
| Cash from discontinued investing activities | ||||
| Investing cash flow | -2,381.23%-40.04M | 53.90%-1.61M | -503.12%-3.5M | ---580.45K |
| Financing cash flow | ||||
| Cash flow from continuing financing activities | -25.26%31.94M | 4,392.26%42.73M | -101.14%-995.47K | 87.55M |
| Net common stock issuance | -17.76%35M | --42.56M | ---- | --89.62M |
| Net other financing activities | -1,895.56%-3.06M | 117.14%170.58K | 51.82%-995.47K | ---2.07M |
| Cash from discontinued financing activities | ||||
| Financing cash flow | -25.26%31.94M | 4,392.26%42.73M | -101.14%-995.47K | --87.55M |
| Net cash flow | ||||
| Beginning cash position | 36.12%69.58M | -36.80%51.11M | 859.52%80.88M | --8.43M |
| Current changes in cash | -311.09%-38.97M | 162.02%18.46M | -141.08%-29.77M | --72.45M |
| End cash Position | -56.01%30.61M | 36.12%69.58M | -36.80%51.11M | --80.88M |
| Free cash from | -33.30%-31.17M | 17.51%-23.38M | -85.95%-28.35M | ---15.25M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data